Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Career
    • Practice Management
      • Reimbursement & Coding
      • Legal
      • Operations
    • Awards
    • Certification
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Compensation Reports
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • By the Numbers
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • mTBI Resource Center
    • ACEP.org
    • ACEP Knowledge Quiz
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • Issue Archives
  • Archives
    • Brief19
    • Coding Wizard
    • Images in EM
    • Care Team
    • Quality & Safety
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

New Developments in Direct Oral Anticoagulant Safety and Indications

By Ryan Patrick Radecki, MD, MS | on September 14, 2015 | 0 Comment
CME CME Now Pearls From the Medical Literature
Share:  Print-Friendly Version
New Developments in Direct Oral Anticoagulant Safety and Indications
You Might Also Like
  • NOAC Bleeding No More Dangerous than Warfarin Bleeding
  • A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab
  • Should You Use Direct Oral Anticoagulants for Cancer-Associated VTE?
Explore This Issue
ACEP Now: Vol 34 – No 09 – September 2015

Pages: 1 2 3 | Single Page

Topics: Clinical GuidelinesCMECritical CareDabigatranDirect Oral AnticoagulantsEmergency DepartmentEmergency MedicineEmergency Physician

Related

  • Phenylephrine and Epinephrine Push-Dose Vasopressors

    February 10, 2026 - 0 Comment
  • Why the Nonrebreather Should be Abandoned

    December 3, 2025 - 0 Comment
  • Non-Invasive Positive Pressure Ventilation in the Emergency Department

    October 1, 2025 - 0 Comment

Current Issue

ACEP Now: February 2026 (Digital)

Read More

About the Author

Ryan Patrick Radecki, MD, MS

Ryan Patrick Radecki, MD, MS, is an emergency physician and informatician with Christchurch Hospital in Christchurch, New Zealand. He is the Annals of Emergency Medicine podcast co-host and Journal Club editor and can be found on Twitter @emlitofnote.

View this author's posts »

No Responses to “New Developments in Direct Oral Anticoagulant Safety and Indications”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*



Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603